Browsing by Subject
Ara mostrant els elements 1-9 d 9
-
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer
(Future Medicine, 2023-08) -
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
(American Society of Clinical Oncology, 2020-09-10) -
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
(American Association for Cancer Research, 2023-11-15)